Jozsef Toldi
Szeged, CS 6725, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
The Power Struggle: Kynurenine Pathway Enzyme Knockouts and Brain Mitochondrial Respiration.
Journal: Journal of neurochemistry
Published: October 15, 2024
Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 15, 2024
Age-dependent changes in NMDA-induced excitotoxicity and neuromodulatory effects of kynurenic acid and its analogue in mouse brain slices.
Journal: Neuroscience letters
Published: July 11, 2024
Kynurenic acid and kynurenine aminotransferase are potential biomarkers of early neurological improvement after thrombolytic therapy: A pilot study.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: October 12, 2021
Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma.
Journal: Heliyon
Published: October 13, 2020
Species-specific neuronal localization of kynurenine aminotransferase-2 in the mouse cerebellum.
Journal: Neurochemistry international
Published: May 01, 2020
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.
Journal: International journal of molecular sciences
Published: February 28, 2020
Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs.
Journal: Molecules (Basel, Switzerland)
Published: September 12, 2019
Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease.
Journal: Expert opinion on therapeutic targets
Published: November 20, 2018
Last Updated: 09/26/2026